Auflistung nach Autor "Haedicke-Jarboui, Juliane"

Anzeige der Dokumente 1-14 von 14

A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo

Notz, Ekaterina; Stubenrauch, Frank; Iftner, Thomas; Leiprecht, Natalie Simone; Schütz, Johanna Elisabeth; Haedicke-Jarboui, Juliane (2014)
A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

Iftner, Thomas; Holz, Barbara; Haedicke-Jarboui, Juliane; Iftner, Angelika (2014)
A review of the clinical performance of the Aptima HPV assay

Haedicke-Jarboui, Juliane; Iftner, Thomas (2016)
Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy

Rataj, Olga; Haedicke-Jarboui, Juliane; Stubenrauch, Frank; Iftner, Thomas (2019)
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

Iftner, Thomas; Becker, Sven; Iftner, Angelika; Holz, Barbara; Staebler, Annette; Henes, Melanie; Rall, Katharina; Haedicke-Jarboui, Juliane; Hann von Weyhern, Claus; Brucker, Sara (2015)
HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections

Manawapat-Klopfer, Anna; Wang, Lisa Yuan; Haedicke-Jarboui, Juliane; Stubenrauch, Frank; Martus, Peter; Iftner, Thomas (2018)
Human papillomaviruses and cancer

Iftner, Thomas; Haedicke-Jarboui, Juliane (2013)
Involvement of Brd4 in different steps of the papillomavirus life cycle

Iftner, Thomas; Haedicke-Jarboui, Juliane (2017)
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Iftner, Thomas; Holz, Barbara; Iftner, Angelika; Staebler, Annette; Wallwiener, Diethelm; Neis, Felix; Haedicke-Jarboui, Juliane; Martus, Peter; Brucker, Sara; Henes, Melanie; Hann von Weyhern, Claus (2019)
Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence : A prospective large cohort study using cervical swab samples

Fertey, Jasmin; Ruscheweyh, Hans-Joachim; Huson, Daniel; Haedicke-Jarboui, Juliane; Stubenrauch, Frank; Iftner, Thomas; Hagmann, Jörg (2019)
Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

Iftner, Thomas; Haedicke-Jarboui, Juliane (2019)
Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up

Iftner, Thomas; Haedicke-Jarboui, Juliane (2019)
Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged >= 30 years using residual LBC ThinPrep specimens

Iftner, Thomas; Iftner, Angelika; Holz, Barbara; Haedicke-Jarboui, Juliane; Iftner, Nathalie; Martus, Peter; Wang, Lisa Yuan (2016)
TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions

Manawapat-Klopfer, Anna; Martus, Peter; Stubenrauch, Frank; Iftner, Thomas; Haedicke-Jarboui, Juliane (2016)

Anzeige der Dokumente 1-14 von 14

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Haedicke-Jarboui, Juliane"

Auflistung nach Autor "Haedicke-Jarboui, Juliane"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos